MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Wednesday, September 25, 2019

1:15pm-2:45pm
“Poised for Parkinson’s”: Group classes in Alexander technique for managing symptoms of Parkinson’s disease

M. Gross, R. Ravichandra, M. Norcia, R. Cohen (Moscow, ID, USA)

Non-Pharmacological Interventions  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
“Brain-first” vs. “body-first” Parkinson’s disease is determined by RBD-status – a multi-modality imaging study

J. Horsager, K. Knudsen, K. Andersen, C. Skjærbæk, T. Fedorova, J. Geday, J. Kraft, E. Bech, E. Danielsen, M. Møller, N. Pavese, D. Brooks, P. Borghammer (Aarhus N, Denmark)

Neuroimaging  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
“Dual Frequency” Deep Brain Stimulation Paradigm for Axial Symptoms in Parkinson’s Disease

J. Karl, B. Ouyang, L. Verhagen Metman (Chicago, IL, USA)

Surgical Therapy  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
(Not) sleeping with the enemy: Cognitive correlates of nocturnal sleep disturbances in Parkinson’s disease

S. Castillo-Torres, C. Cerda-Contreras, D. Roque-Martínez, D. Díaz-Pérez, X. Ortiz-Jiménez, B. Chávez-Luévanos, I. Estrada-Bellmann (Monterrey, Mexico)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
11C-PBB3 PET in PD: does alpha-synuclein pathology start in axonal terminals?

M. Matarazzo, A. Pérez-Soriano, V. Sossi, N. Vafai, E. Shahinfard, K. Ju-Chieh Cheng, J. Mckenzie, N. Neilson, Q. Miao, H. Shinotoh, M. Higuchi, A. Stoessl (Vancouver, BC, Canada)

Neuroimaging  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
18F-DPA714 PET reveals neuroinflammatory activity in the Substantia nigra of patients with Parkinson disease

S. Lavisse, C. Wimberley, S. Goutal, M. Bottlaender, B. Kuhnast, MA. Peyronneau, M. Sarazin, P. Hantraye, C. Thiriez, P. Remy (Fontenay Aux Roses, France)

Neuroimaging  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
A case of dystonia with dystonic tremor treated with DBS targeting the VOA and VIM thalamus

L. Jackson, B. Klassen, J. Bower, F. Ali (Rochester, MN, USA)

Surgical Therapy  ·  Les Muses Terrace, Level 3
1:15pm-2:45pm
A Comparative Study of Measured and Predicted Metrics of Respiratory Function in People with Parkinson’s Disease (PD)

L. Mcmahon, O. Lennon, C. Blake, D. Mcgrath (Dublin, Ireland)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
1:15pm-2:45pm
A comparison of serial position effects between patients with MCI due to Parkinson’s disease and patients with MCI due to Alzheimer’s disease

A. Meyer, I. Handabaka, MM. Ehrensperger, U. Gschwandtner, F. Hatz, AU. Monsch, RD. Stieglitz, P. Fuhr (Basel, Switzerland)

Cognition and Cognitive Disorders  ·  Agora 3 East, Level 3
1:15pm-2:45pm
A Dual-Center Study of Pain and Other Non-motor Symptoms in Parkinson disease

P. Ghosh, P. Imbriani, N. Caputi, L. Covington, A. Sparks, T. Schirinzi, Y. Salnikova, S. Natoli, A. Pisani (Washington Dc, DC, USA)

Non-Motor Symptoms  ·  Agora 3 West, Level 3
  • 1
  • 2
  • 3
  • …
  • 67
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley